Centene Reports Unexpected Q2 2025 Loss, Slashes Outlook Amid Marketplace Headwinds
- Centene reported a Q2 2025 adjusted loss per share of $0.16, missing analyst expectations for a $0.23 profit per share [3].
- The company lowered its full-year 2025 adjusted diluted EPS outlook to approximately $1.75 [4].
- Significant headwinds in Centene’s Health Insurance Marketplace segment contributed to a forecasted $2.4 billion drag for the year [4].
- Q2 operating revenue was $42.5 billion, an 18% increase from the prior year [2].
- Despite strong cash flow from operations of $1.8 billion, profitability declined sharply [4].
Centene Corporation reported a surprise loss for the second quarter of 2025 and sharply cut its full-year earnings forecast due to worsening pressures in its Health Insurance Marketplace business.
Q2 2025 Financial Results
Centene recorded an adjusted diluted loss per share of $0.16 for the second quarter of 2025, falling short of analyst expectations for a $0.23 profit per share. The company also reported a GAAP net loss per share of $0.51 [3]. Operating revenue for the quarter was $42.5 billion, up 18% from $36.0 billion in the prior year period [2]. Cash flow from operations was $1.8 billion, reflecting continued strength in liquidity.
Marketplace Segment Pressure
Centene identified substantial ongoing challenges in its Health Insurance Marketplace segment as the primary contributor to its disappointing results. The company now projects a $2.4 billion annual headwind from this business, driven by adverse selection and higher-than-anticipated medical costs [4]. This segment’s performance overshadowed gains in other areas of the company’s business.
Revised 2025 Outlook
In response to these results, Centene revised its full-year 2025 adjusted diluted earnings per share guidance to approximately $1.75, down from prior projections. The company said it is taking actions to manage costs and reassess its Marketplace strategy to address deteriorating profitability [4].
Revenue and Membership Overview
Despite the disappointing bottom line, Centene’s revenue growth was robust, and its total membership base remained strong. The company remains a key player in government-sponsored health programs, with a broad national footprint [5].